Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I
Open Access
- 30 December 2009
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 40 (1), 172-185
- https://doi.org/10.1002/eji.200939280
Abstract
The complement system is regulated by inhibitors such as factor I (FI), a serine protease that degrades activated complement factors C4b and C3b in the presence of specific cofactors. Mutations and polymorphisms in FI and its cofactors are associated with atypical hemolytic uremic syndrome (aHUS). All 14 complement factor I mutations associated with aHUS analyzed in this study were heterozygous and generated premature stop codons (six) or amino acid substitutions (eight). Almost all of the mutants were expressed by human embryonic kidney 293 cells but only six mutants were secreted into the medium, three of which were at lower levels than WT. The remaining eight mutants were not secreted but sensitive to deglycosylation with endoglycosidase H, indicating that they were retained early in the secretory pathway. Six secreted mutants were purified and five of them were functionally altered in degradation of C4b/C3b in the fluid‐phase in the presence of various cofactors and on endothelial cells. Three mutants cleaved surface‐bound C3b less efficiently than WT. The D501N mutant was severely impaired both in solution and on surface irrespective of the cofactor used. In conclusion, mutations in complement factor I affect both secretion and function of FI, which leads to impaired regulation of the complement system in aHUS.Keywords
This publication has 44 references indexed in Scilit:
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndromeBlood, 2008
- Where next with atypical hemolytic uremic syndrome?Molecular Immunology, 2007
- A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulationMolecular Immunology, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences of the United States of America, 2007
- Atypical haemolytic uraemic syndromeBritish Medical Bulletin, 2006
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeBlood, 2006
- Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated HerpesvirusOnline Journal of Public Health Informatics, 2003
- CCP1–4 of the C4b-binding protein α-chain are required for factor I mediated cleavage of complement factor C3bMolecular Immunology, 2003
- The molecular basis of hereditary complement factor I deficiency.JCI Insight, 1996
- Processing of human factor I in COS-1 cells co-transfected with factor I and paired basic amino acid cleaving enzyme (PACE) cDNAMolecular Immunology, 1995